Next Generation Sequencing (NGS) Data Analysis: Global Market Analysis and Forecast to 2026 – ResearchAndMarkets.com

Dublin – (work wire) – “Next Generation Sequencing (NGS) Data Analysis – Global Market Path and Analytics” report has been added to ResearchAndMarkets.com Show.

The Global Next Generation Sequencing (NGS) Data Analysis Market Will Reach US$ 1.2 Billion by 2026

The growth in the global market is set to be driven by the widespread uptake of RNA and DNA sequencing technology. Cloud-based platforms are rapidly emerging as favorable solutions for performing extensive computational activities while analyzing NGS data making it quick and simple for researchers to obtain computational resources to perform large-scale data analysis of NGS. Recent technological advances in cloud computing and bioinformatics have led to the development of a wide range of cloud-based bioinformatics platforms and services for large-scale NGS data analysis, which is likely to drive significant growth in the market in the coming years.

NGS methods are widely used in genomic research, clinical diagnosis and precision oncology, especially for breast and lung cancer diagnosis. The increasing prevalence of cancer cases across the globe is expected to boost the growth of the global NGS data analysis market in the near future. Moreover, with significant progress towards personalized treatment of diseases, there is a growing demand for fast and accurate sequencing interpretation algorithms and tools that can help speed up data analysis.

Amidst the COVID-19 crisis, the global Next Generation Sequencing (NGS) Data Analytics Market of 549.2 Million USD in 2020, is expected to reach a revised size of 1.2 Billion USD by 2026, at a CAGR of 14.1% over the period analysis. Services, one of the sectors analyzed in the report, is expected to grow at a CAGR of 14.9% to reach $814.1 million by the end of the analysis period.

After a thorough analysis of the business implications of the pandemic and the resulting economic crisis, the growth in the NGS business software sector has been readjusted to a compound annual growth rate of 13% for the next seven years. This segment currently accounts for a 44% share of the global Next Generation Sequencing (NGS) data analysis market.

Analytical software is expected to show strong growth over the next few years, owing to increased awareness and increased demand for sequencing technologies. The massive amounts of data being generated via NGS require management platforms and solutions, which leads to an increased demand for these algorithms and tools. Companies that lack the infrastructure to analyze, interpret, and manage data are increasingly relying on cost-effective NGS data analytics services.

The US market size is estimated at $238.7 million in 2021, while China is expected to reach $128.6 million by 2026.

The Next Generation Sequencing (NGS) data analytics market in the United States is estimated at $238.7 million in 2021. The country currently accounts for 37.6% of the global market share. China, the world’s second largest economy, is expected to reach an estimated market size of US$128.6 million in 2026, trailing a compound annual growth rate of 15.1% during the analysis period.

Other noteworthy geographic markets include Japan and Canada, both of which are expected to grow at 12.8% and 13.3% respectively during the analysis period. Within Europe, Germany is expected to grow at a CAGR of approximately 14.1% while the rest of the European market (as defined in the study) will reach $101.9 million by the end of the analysis period. The United States is a major regional market for NGS data analysis, owing to the presence of many well-established players, the growing demand for personalized medicine, and the launch of several large-scale genome sequencing projects in the region.

Europe is another major market. The dominance of the region is attributed to the presence of several major global players, including Agilent Technologies, Illumina and Thermo Fisher Scientific, along with a large number of regional players involved in the development of NGS data analysis software. There are also several European universities that are involved in conducting several NGS research projects, which are driving the adoption of NGS software tools in the region.

Select competitors (a total of 111 featured)

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • Congenica Ltd.

  • DNAnexus Corporation

  • Dnastar, Inc.

  • Eurofins Scientific

  • F. Hoffmann-La Roche Ltd.

  • Genomics Textile, Inc.

  • ethnology

  • Golden Helix, Inc.

  • Illumina, Inc.

  • Intrexon Bioinformatics Germany GmbH

  • Pacific Biosciences of California, Inc.

  • Partic Incorporated

  • Perian DX

  • Qiagen

  • SciGenom Laboratories Pvt. Ltd.

  • Genetics Sophia

  • Thermo Fisher Scientific, Inc.

Main topics covered

I. METHODOLOGY

Secondly. Executive Summary

1. Market Overview

  • NGS Data Analysis: Uncovering Critical Clues to Solve Scientific Problems

  • NGS Data Analysis: Insights into File Formats and Downstream Analysis

  • File Formats for NGS Raw Data

  • NGS data: downstream analysis

  • The impact of Covid-19 and the looming global recession

  • 2020 is a year of turmoil and transformation

  • The never-ending “race” between viruses and vaccines continues. In the midst of this chaotic battle, where is the global economy heading now and beyond?

  • Omicron panic spreads all over the world; Omicron Variant brings back memories and fears from the worst part of the 2020 pandemic

  • Omicron’s short-term effect on travel

  • Financial Impact

  • Scientists seek to gather more information about Omicron

  • Pharmaceutical companies aim to improve existing vaccines against Omicron

  • Omicron: Impact on the Travel Industry

  • Steps Taken by States to Prevent Transmission of Variant Omicron

  • With the International Monetary Fund carrying out an upward review of global GDP for 2021, companies are optimistic about the return to the economy despite the ongoing pandemic

  • Impact of COVID-19 on Next Generation Sequencing (NGS) data analysis

  • NGS’ Great Promise in Combating COVID-19 Highlights NGS Data Analysis Market

  • Global market overview and forecast

  • Next Generation Sequencing (NGS) data analysis market is growing

  • The main drivers and disincentives of the market

  • market analysis

  • The United States and Europe are at the fore, Asia and the Pacific to witness growth

  • Analysis by product

  • Workflow analysis

  • Analysis by situation

  • Analysis by reading length

  • Analysis by end use

  • Competitive scene

  • Recent market activity

2. Focus on identifying players

3. Market trends and drivers

  • Next Generation Serialized Market Growth Drives Demand for NGS Data Analysis

  • Increase research and development activities in NGS

  • Growing Use of NGS in Drug Discovery Engines, NGS Data Analysis Growth

  • The increasing application of whole genome sequencing is increasing the demand for faster secondary analysis tools

  • Technological advances in sequencing and data integration techniques

  • Research initiatives to develop laboratory diagnostics based on NGS

  • Need for large-scale NGS data analysis drives cloud-enabled bioinformatics services

  • NGS Data Analysis Using Big Data Gains

  • Optimizing the regulation and reimbursement scenario for NGS-based diagnostic tests

  • Increased genome mapping software

  • Lower costs of genome sequencing lead to market growth

  • Long Read Sequence Growth to Drive NGS Data Analysis Market

  • The demographics of aging present opportunities

  • Increasing prevalence of chronic diseases to enhance market prospects

  • Market Challenges

4. Global market perspective

Third. market analysis

Fourthly. Competition

  • Total listed companies: 111

For more information on this report, visit https://www.researchandmarkets.com/r/17nfev

Leave a Comment